Methadone: The question or the answer for US opioid therapy and pharmaco-economics? [1]

Supportive Care in Cancer

Volumn 9, Issue 8, 2001, Pages 646-647

  Duke Dickerson, E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROMORPHONE; METHADONE; OPIATE; OXYCODONE;

ANALGESIA; CANCER PAIN; DRUG COST; LETTER; PALLIATIVE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANALGESICS, OPIOID; HUMANS; METHADONE; MODELS, THEORETICAL; NEOPLASMS; OPIOID-RELATED DISORDERS; PAIN;

EID: 0035165033     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200100266     Document Type: Letter

References (19)

1. New approaches to pain control in patients with cancer
2. Criteria for opioid selection
3. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine
4. Methadone for relief of cancer pain: A review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration
5. 20 Essential drugs in palliative care
6. Opioids in pain management
7. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home
8. The use of methadone in cancer pain poorly responsive to other opioids
9. German model for methadone conversion
10. Palliative care and hospice opioid dosing guidelines with break-through pain doses
11. Opioid and adjuvant analgesics
12. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?
13. Gli oppioidi analgesici
14. Clinical applications of methadone
15. Opioids in cancer pain - Which one is best?